July 2, 2020

Volume X, Number 184

Life Sciences Roundtable Series: Structuring Milestones and Contingent Payments in Biotech, Pharma, and Medtech M&A and Collaborations: U.S. and European Trends

McDermott Will & Emery, JSB-Partners and SRS Acquiom cordially invite you to a complimentary Life Sciences Roundtable and evening reception. JSB-Partners will present recent data from their experience managing over 100 life sciences M&A deals, and our interactive panel will address the key issues and recent trends involved in structuring milestone and contingent payments in collaboration and M&A agreements in both the United States and Europe.

Our panelists will address the following critical issues related to pharmaceutical and medtech deal-making:

    Key factors to consider when structuring and drafting clinical, regulatory and sales-based milestone payments

    Drafting “due diligence” obligations, and the definition of “commercially reasonable efforts”

    Recent developments in life sciences litigation involving milestone payments, earn-outs, contingent consideration and royalty payments


Michel Gouy, Partner, JSB-Partners

Amanda Jackson, Director, Business Development, SRS Acquiom

Anthony Paronneau, Partner, McDermott Will & Emery LLP

Emmanuelle Trombe, Partner, McDermott Will & Emery LLP

Kristian A. Werling, Partner, McDermott Will & Emery LLP

Event Location: 
McDermott Will & Emery 23 rue de l’Université 75007 Paris